Patents
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
08/2002
08/22/2002CA2436195A1 Laulimalide derivatives
08/21/2002CN1365278A Water soluble trioxanes as potent and safe anti-malarial agents
08/20/2002US6438244 Hearing aid construction with electronic components encapsulated in soft polymeric body
08/20/2002US6437045 Powder coating of carboxyl polyester or (poly)methacrylate and cycloaliphatic polyepoxide
08/15/2002WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors
08/15/2002WO2002028866A3 Hydroxyesters of 7-desmethylrapamycin
08/15/2002WO2001079246A3 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
08/14/2002EP1230243A1 Poycyloalkylpurines as adenosine receptor antagonists
08/14/2002EP1230232A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
08/14/2002EP0708761B1 Enhanced relaxivity monomeric and multimeric compounds
08/14/2002DE10104350A1 Verfahren zur Herstellung von Flavon Derivaten A process for producing flavone derivatives
08/14/2002CN1363218A Use of oxabiscycle [2,2,1] heptadiene derivative as agricultural chemical
08/14/2002CN1089086C Luminide and macroluminide class of pharmaceuticals
08/13/2002US6434248 Soft hearing aid moulding apparatus
08/13/2002US6433190 Use as a monomer for polyimides with high glass transition temperature, low dielectric constant and excellent processability
08/13/2002US6433189 Tricyclic and tetracyclic taxane intermediates
08/13/2002US6433187 Certain polycyclic compounds useful as tubulin-binding agents
08/13/2002US6433165 Chemokine receptor antagonists and methods of use therefor
08/13/2002US6433004 Substituted β,γ-anellated lactones
08/13/2002US6432247 Method of manufacturing a soft hearing aid
08/13/2002CA2212357C 10-deacetyl-14beta-hydroxybaccatine iii derivatives, a process for the preparation thereof and formulations containing them
08/08/2002WO2002060905A2 Process for preparing intermediates of hiv protease inhibitors
08/08/2002WO2002060890A1 Novel physiologically active substances
08/08/2002WO2002060889A1 Method for producing flavone derivatives
08/08/2002WO2002060436A2 Use of fredericamycin a and its derivatives in the treatment of pin1-associated states
08/08/2002WO2002046179A8 (meth)acrylate esters, starting alcohols for the preparation thereof, processes for preparing both, polymers of the esters, chemically amplifiable resist compositions, and method for forming patterns
08/08/2002CA2432981A1 Use of fredericamycin a and its derivatives in the treatment of pin1-associated states
08/07/2002EP1228087A1 Antibody catalysis of enantio- and diastereo-selective aldol reactions
08/07/2002EP1228024A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
08/07/2002EP1058679A4 Synthesis of epothilones, intermediates thereto and analogues therof
08/07/2002EP0975638B1 Epothilones with a modified side chain
08/07/2002CN1362397A Dialkoyl-halogen phenyl substituted keto-enol
08/07/2002CN1362252A Method of eliminating gingkolic acid from gingko extract
08/07/2002CN1088708C Amidine derivatives useful as anti-platelet aggreaction inhibitors and vasodilators and their use
08/06/2002US6429281 Curable; nonhydrolyzing thermosetting resins
08/06/2002US6429203 Farnesyl-protein transferase inhibitors
08/01/2002WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors
08/01/2002WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors
08/01/2002WO2002058701A1 Pharmaceutical dosage forms of epothilones for oral administration
08/01/2002WO2002058699A1 Pharmaceutical forms of epothilones for oral administration
08/01/2002WO2002058639A2 Pyranoflavonoid compounds and their use as estrogen receptor modulators
08/01/2002US20020103386 Physalis angulata extracts, particularly ergostane-type steroidal derivatives, physalins, useful as antiprotozoa agents and as immunomodulators
08/01/2002US20020103385 Use as a monomer for polyimides with high glass transition temperature, low dielectric constant and excellent processability
08/01/2002US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
08/01/2002CA2434584A1 Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones
07/2002
07/31/2002EP1226145A1 Naphthopyrans with a heterocycle in the 5,6-position, preparation, and compositions and matrices containing them
07/31/2002EP1226142A2 Process for the production of epothiolone b and derivatives as well as intermediate products for this process
07/31/2002EP1226134A2 Naphthopyrans having a perfluoroalkyl substituent in position 5, preparation and compositions and matrices containing them
07/31/2002CN1361765A Inhibitors of aspartyl protease
07/31/2002CN1361687A Phosphate transport inhibitors
07/30/2002US6426023 Benzopyrans annelated in C7-C8 with an aromatic heterocycle and compositions and (CO)polymer matrices containing them
07/30/2002CA2054342C Azolylmethylspiro [2.5] octanols and fungicides containing these
07/25/2002WO2002057259A2 Pyrazole compounds useful as protein kinase inhibitors
07/25/2002WO2002056835A2 Anticancer treatment using triptolide prodrugs
07/25/2002WO2002044161A3 A process for the preparation of taxan derivatives
07/25/2002US20020099168 For incorporation into thermosetting resins; less susceptible to popcorning upon cure or use in high temperature applications
07/25/2002US20020099051 Anticancer treatment using triptolide prodrugs
07/25/2002CA2435322A1 Anticancer treatment using triptolide prodrugs
07/24/2002EP1225175A1 Synthesis of D-chiro-3-inosose and (+)-D-chiro-inositol
07/24/2002EP1224316A2 13-alkyl epothilone derivatives
07/24/2002EP1224184A1 Novel limonoids for use particularly in the treatment of cancer and method for producing the same
07/24/2002EP0889041B1 Novel iridoid derivatives and neovascularization inhibitors containing the same as active ingredient
07/24/2002EP0876374B1 Method for preparing 4'-demethylepipodophyllotoxin from podophyllotoxin
07/24/2002CN1088067C Separating method for sesanins
07/23/2002US6423865 Compounds and their application as well as a method of producing liquid crystalline polymers therefrom
07/23/2002US6423853 In solvent with carrier gas
07/23/2002US6423850 Preparation and use of gamma-butyrolactones as cross-linking agents
07/18/2002WO2002055523A1 Mikanolide derivatives, their preparation and therapeutic uses
07/18/2002WO2002055522A2 Novel multi-ring organic compounds for regulating gut motility and food intake
07/18/2002US20020095061 Enantioselectivity; epoxidizing and hydrolyzing the geranyloxy compound
07/18/2002US20020095046 For colouring/pigmenting high-molecular-weight organic material
07/18/2002US20020094960 Specifically unipolar depression, treatment-refractory depression, resistant depression, anxious depression and dysthymia; 2-sulfamatomethyltetrahydropyrans and sulfamato-methylcyclohexanes, e.g. topiramate
07/18/2002US20020094568 Apparatus for reducing concentration of low molecular weight compounds in biological composition
07/18/2002CA2433981A1 Mikanolide derivatives, their preparation and therapeutic uses
07/18/2002CA2433066A1 Novel multi-ring organic compounds for regulating gut motility and food intake
07/17/2002EP1222192A1 Hexahydrofuro[2,3-b]furan-3-yl-n- 3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl carbamate as retroviral protease inhibitor
07/17/2002EP1222184A2 Preparation and use of gamma-butyrolactones as cross-linking agents
07/17/2002EP1221939A1 Ortho ester lipids
07/17/2002EP1100520A4 Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof
07/17/2002CN1359384A Taxane derivatives and processes for the preparation thereof
07/17/2002CN1358724A Improved process for rifa high-density raw powder I type crystal
07/16/2002US6420571 Methods for preparing antiviral calanolide compounds
07/16/2002US6420570 Psoralen compounds
07/16/2002US6420569 Process for producing pyrone compounds
07/16/2002US6420370 Pyrimidine derivatives and method of making and using derivatives
07/16/2002US6420334 2-alkoxydecahydro-2,3a,4,4,7-pentamethyl-3,7a-methano-7ah-indeno(5,6-b)furans; etherification and cyclization of hydroxy ketone or enol ether with an alcohol; fragrances; perfumes; stabile; effective; long-lasting
07/16/2002US6420130 Chemical compound for use in the detection of preferential enzymatic polypeptide
07/11/2002WO2002053567A1 Use of oxabicyclo[2.2.1]heptadiene derivatives as pesticidal agents
07/11/2002WO2002053552A1 Process for preparation of esculetin compounds, esculetin compounds and intermediates thereof, and use of both
07/11/2002US20020091269 Synthesis of epothilones and related analogs
07/11/2002US20020091216 5-norbornene-2-carboxylic acid-3-hydroxyethyl carboxylate for example; far ultraviolet photolithography
07/11/2002US20020091151 Novel macrocycles and uses thereof
07/11/2002US20020091134 Novel 4-phenyl substituted tetrahydroiso quinolines therapeutic use thereof
07/11/2002CA2433578A1 Process for preparation of esculetin compounds, esculetin compounds and intermediates thereof, and use of both
07/10/2002EP1221445A1 Pentacyclic taxane compounds
07/10/2002CN1358093A Decursinol or derivative thereof as analgesic agent
07/09/2002US6417370 Arylphenyl-substituted cyclic keto-enols
07/09/2002US6417221 Tropane analogs and methods for inhibition of monoamine transport
07/09/2002CA2244519C C-4":substituted macrolide antibiotics
07/09/2002CA2222275C Fluorinated xanthene derivatives